Press-Release

Diagnose Early appoints new CEO and Chief Product Officer

Diagnose Early is delighted to welcome two highly-experienced senior executives to our leadership team.

Menlo Park, CA, November 21, 2023. Diagnose Early Inc. announced the appointment of Richard Kho as Chief Executive Officer and Karim Damji as Chief Product Officer. Richard has a long track record of driving growth in healthcare and technology companies, with a focus on delivering improved patient outcomes. Karim is an industry leader who brings over a decade of product management, technology and marketing experience in the digital health space. 

“I am delighted to be joining Diagnose Early at this crucial stage in their evolution”, said Richard. “The company is set to become a key player in the rapidly expanding health data market. We have developed a proprietary health data platform that is backed up by novel non-invasive breath analysis data. This combination will help us deliver a vision of data-driven preventative healthcare for our key partners in the First Responder community.”

“I’m delighted that Richard and Karim have agreed to join us,” said Nick Giannasi PhD, Chairman of the Diagnose Early Board. “They join a rapidly growing team of top talent at Diagnose Early. Richard’s strong leadership experience will be critical in helping us deliver our vision for the future. Meanwhile, Karim’s ability to lead teams through their critical growth stage in the health data space is exemplary. His product experience will be crucial as we develop cutting edge technology to make a real difference to our end users” 

“Our board is pleased to bring on such renowned leaders to help Diagnose Early pursue the immense market opportunity we have identified,” said Bob Dykes, Interim CEO and Member of the Board of Diagnose Early. “Richard and Karim joining furthers my belief that we will execute on our vision for data-driven preventative healthcare. Together, they will be pivotal in ensuring Diagnose Early becomes a real disruptor in the health data market.”

Richard holds a PhD in toxicology and an MBA from USC Marshall School of Business. He is a serving board member of Sentinel Node Oncology Foundation. Before joining Diagnose Early, he was COO & a member of the Board for Iterative Health. Prior to that he was Chief Commercial Officer of Picnic Health and Chief Revenue Officer at Komodo Health.

Karim has a degree in Applied Maths and Computer Science from San Jose State University. He began his career at Cisco. He went on to founding roles in several companies, starting with Founding Head of Product at Vocera Communications. Since then, his career has increasingly focused on life sciences and health data. Recent highlights include product and marketing leadership roles at Saama, Verana Health and Model N. Karim is also an active startup advisor, investor and an acknowledged expert in the application of AI to healthcare.

Diagnose Early appoints new CEO and Chief Product Officer

About Diagnose Early

Diagnose Early is bringing non-invasive breath and biometric testing to the world through our proprietary breath analysis technology and AI health data platform. 

A key data source is our breath testing technology, which is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes.

The Diagnose Early health data platform allows users to collect their health data in one place, providing them with a longitudinal lifetime record for the future. This data can be analyzed by our proprietary AI or deidentified and shared with others to advance medical research.